Secondary malignancy after carbon ion radiotherapy in a 15-year-old female with Ewing sarcoma

Affiliations

¹ Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
² Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.
³ Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan.
⁴ Department of Pathology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Editorial

Eri Ushida et al. Pediatr Blood Cancer. 2023 Dec.

. 2023 Dec;70(12):e30676.

doi: 10.1002/pbc.30676. Epub 2023 Sep 13.

¹ Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
² Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.
³ Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Japan.
⁴ Department of Pathology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

No abstract available

References

1. Imai R, Kamada T, Araki N. Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma. Cancer Med. 2018;7(9):4308-4314.
1. Combs SE, Nikoghosyan A, Jaekel O, et al. Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base. Cancer. 2009;115(6):1348-1355.
1. Mohamad O, Imai R, Kamada T, Nitta Y, Araki N. Carbon ion radiotherapy for inoperable pediatric osteosarcoma. Oncotarget. 2018;9(33):22976-22985.
1. Khanna L, Prasad SR, Yedururi S, et al. Second malignancies after radiation therapy: update on pathogenesis and cross-sectional imaging findings. Radiographics. 2021;41(3):876-894.
1. Panse G, Mito JK, Ingram DR, et al. Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation. Histopathology. 2021;78(2):321-326.